Positive News SentimentPositive NewsNASDAQ:DVAX Dynavax Technologies (DVAX) Short Interest Ratio & Short Volume $11.20 +0.12 (+1.08%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$11.05▼$11.3650-Day Range$9.62▼$11.4652-Week Range$9.42▼$17.48Volume1.09 million shsAverage Volume1.32 million shsMarket Capitalization$1.43 billionP/E Ratio7.18Dividend YieldN/APrice Target$24.00 Short InterestProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Dynavax Technologies Short Interest DataCurrent Short Volume18,360,000 sharesPrevious Short Volume18,040,000 sharesChange Vs. Previous Month+1.77%Dollar Volume Sold Short$210.41 millionShort Interest Ratio / Days to Cover13.2Last Record DateMay 15, 2023Outstanding Shares127,700,000 sharesPercentage of Shares Shorted14.38%Today's Trading Volume1,087,093 sharesAverage Trading Volume1,316,400 sharesToday's Volume Vs. Average83% Short Selling Dynavax Technologies ? Sign up to receive the latest short interest report for Dynavax Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDVAX Short Interest Over TimeDVAX Days to Cover Over TimeDVAX Percentage of Float Shorted Over Time Dynavax Technologies (NASDAQ:DVAX) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202318,360,000 shares $210.41 million +1.8%N/A13.2 $11.46 4/30/202318,040,000 shares $187.80 million -0.2%N/A13.1 $10.41 4/15/202318,070,000 shares $200.94 million -0.9%N/A12.8 $11.12 3/31/202318,230,000 shares $178.84 million +2.2%N/A12.6 $9.81 3/15/202317,840,000 shares $173.94 million +10.4%N/A12 $9.75 2/28/202316,160,000 shares $166.45 million -13.3%N/A10 $10.30 2/15/202318,640,000 shares $213.43 million +25.5%N/A11.7 $11.45 1/31/202314,850,000 shares $168.99 million +12.8%N/A9.1 $11.38 1/15/202313,170,000 shares $149.48 million +2.9%N/A7.5 $11.35 12/30/202212,800,000 shares $136.19 million -7.3%N/A7.2 $10.64 12/15/202213,800,000 shares $153.87 million -0.1%N/A7.4 $11.15 11/30/202213,820,000 shares $171.51 million -12.1%N/A7.4 $12.41 11/15/202215,730,000 shares $206.22 million +9.2%N/A8.5 $13.11 10/31/202214,400,000 shares $164.88 million -17.8%N/A6.8 $11.45 10/15/202217,520,000 shares $187.64 million +3.0%N/A8 $10.71 9/30/202217,010,000 shares $177.58 million +7.5%N/A8.2 $10.44 9/15/202215,830,000 shares $182.20 million +0.9%N/A7.7 $11.51 8/31/202215,690,000 shares $179.96 million -7.7%N/A7.5 $11.47 8/15/202217,000,000 shares $265.54 million -5.5%N/A7.3 $15.62 7/31/202217,990,000 shares $258.70 million -7.2%N/A6.1 $14.38 7/15/202219,380,000 shares $280.23 million +2.3%N/A6.8 $14.46 6/30/202218,950,000 shares $238.58 million -2.9%N/A6.6 $12.59 6/15/202219,510,000 shares $208.17 million +2.3%31.5%6.9 $10.67 5/31/202219,070,000 shares $226.17 million +8.2%N/A7 $11.86 5/15/202217,630,000 shares $169.25 million No ChangeN/A6.8 $9.60 4/30/202217,630,000 shares $155.67 million +3.0%N/A10.6 $8.83 4/15/202217,120,000 shares $179.93 million +1.0%N/A10.3 $10.51 3/31/202216,950,000 shares $183.74 million -0.7%N/A9.7 $10.84 3/15/202217,070,000 shares $178.21 million +3.3%N/A9.5 $10.44 2/28/202216,520,000 shares $202.54 million +2.2%N/A8.8 $12.26 2/15/202216,160,000 shares $215.25 million -0.9%14.6%8.7 $13.32 1/31/202216,310,000 shares $211.54 million +4.0%14.7%8.2 $12.97 1/15/202215,690,000 shares $212.29 million +1.2%N/A6.8 $13.53 12/31/202115,510,000 shares $218.23 million -5.5%13.9%6.6 $14.07 12/15/202116,420,000 shares $232.34 million +4.3%14.8%6.1 $14.15 11/30/202115,750,000 shares $254.36 million +3.5%14.2%4.4 $16.15 11/15/202115,220,000 shares $259.50 million -20.2%13.7%3.2 $17.05 10/29/202119,060,000 shares $380.63 million -3.4%17.2%3.9 $19.97 10/15/202119,730,000 shares $334.23 million -2.0%18.6%4.1 $16.94 9/30/202120,130,000 shares $386.70 million -5.9%19.0%4.4 $19.21 DVAX Short Interest - Frequently Asked Questions What is Dynavax Technologies' current short interest? Short interest is the volume of Dynavax Technologies shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 18,360,000 shares of DVAX short. Learn More on Dynavax Technologies' current short interest. What is a good short interest ratio for Dynavax Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DVAX shares currently have a short interest ratio of 13.0. Learn More on Dynavax Technologies's short interest ratio. Which institutional investors are shorting Dynavax Technologies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Dynavax Technologies: Susquehanna International Group LLP, Jane Street Group LLC, Group One Trading L.P., Wolverine Asset Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Dynavax Technologies' short interest increasing or decreasing? Dynavax Technologies saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 18,360,000 shares, an increase of 1.8% from the previous total of 18,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dynavax Technologies' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Dynavax Technologies: Ligand Pharmaceuticals Incorporated (5.03%), Geron Co. (4.54%), MannKind Co. (14.32%), OPKO Health, Inc. (9.82%), Ironwood Pharmaceuticals, Inc. (10.94%), Innoviva, Inc. (13.89%), Lexicon Pharmaceuticals, Inc. (3.40%), Emergent BioSolutions Inc. (14.37%), Intercept Pharmaceuticals, Inc. (9.05%), Vanda Pharmaceuticals Inc. (5.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short Dynavax Technologies stock? Short selling DVAX is an investing strategy that aims to generate trading profit from Dynavax Technologies as its price is falling. DVAX shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dynavax Technologies? A short squeeze for Dynavax Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DVAX, which in turn drives the price of the stock up even further. How often is Dynavax Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DVAX, twice per month. The most recent reporting period available is May, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Ligand Pharmaceuticals Short Interest Data Geron Short Interest Data MannKind Short Interest Data OPKO Health Short Interest Data Ironwood Pharmaceuticals Short Interest Data Innoviva Short Interest Data Lexicon Pharmaceuticals Short Interest Data Emergent BioSolutions Short Interest Data Intercept Pharmaceuticals Short Interest Data Vanda Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DVAX) was last updated on 5/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynavax Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.